Quarterly report pursuant to Section 13 or 15(d)

Going Concern (Details Narrative)

v3.24.1.1.u2
Going Concern (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 15, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Cash   $ 2,419   $ 2,700
Net loss   853 $ 814  
Net cash used in operating activities   1,092 $ 709  
Working capital   $ 2,400    
Registered Direct Offering [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Sale of stock, number of shares issued in transaction 242,891      
Sale of stock, price per share $ 4.22      
Sale of stock, description of transaction each unit consisting of two shares of the Company’s common stock, and a warrant to purchase one share of common stock at an exercise price of $4.00 per share. The $4.22 purchase price equals two times the last reported sale price of $2.11 per share of the Company’s common stock on February 15, 2024 on The Nasdaq Capital Market.      
Class of warrant or right, exercise price of warrants or rights $ 4.00      
Sale of stock, consideration received on transaction $ 1,025